MedPath

Changes in specific antibody titers and interferon gamma levels after a BNT162b2 vaccine booster

Not Applicable
Conditions
COVID-19
Registration Number
JPRN-UMIN000048810
Lead Sponsor
Fukuoka City Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in spike-specific antibody titers and interferon gamma levels 8 months after a BNT162b2 vaccine booster.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath